Earnings
Lineage Starts Manufacturing Work Before Huntington’s Deal — Its Cash Runway Moves Forward One Quarter
Existing supplies cover the planned 21-patient trial, but Lineage still must test its new cell bank and compare production processes.
Lineage Cell Therapeutics (LCTX) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
Existing supplies cover the planned 21-patient trial, but Lineage still must test its new cell bank and compare production processes.
Deals
The acquisition adds a third clinical-stage candidate, with sellers eligible for up to $48 million in development and regulatory milestones.